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Environmental toxicants can exert adverse health effects via epigenetic regulation. We conducted a re-
view of studies assessing traffic-related air pollution (TRAP) exposure and breast cancer (BC) risk, and the
evidence for epigenetic mediation. 14 epidemiological studies demonstrated associations between TRAP
exposure and BC risk, in which a total of 26 comparisons were assessed. 11 of these comparisons reported
a positive association; whereas 15 comparisons were negative. Five publications linked TRAP exposure to
epigenetic alterations in genes that may be related to BC risk. One animal study provided evidence of
TRAP-treatment inducing breast tumorigenesis. Associations between TRAP components polycyclic aro-
matic hydrocarbons (PAH) and nitrogen dioxide (NO2) and BC risk were more consistent. While evidence
for epigenetic regulation remains limited, polycyclic aromatic hydrocarbons (PAH) and nitrogen dioxide
(NO2) exposures may alter methylation of breast tumorigenic genes (e.g., EPHB2, LONP1). Future epige-
nomic studies with environmental measures are needed to interrogate the relationship between TRAP
and BC risk.
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Breast cancer (BC) is the most common cancer among women, leading to high rates of morbidity and mortality [1].
The high incidence of BC remains only partially explained by established risk factors such as age, family history,
BC susceptibility genes, lack of breastfeeding, alcohol intake, cigarette smoking and weight gain in adulthood [2–
4], and by greater BC screening [5]. Population-based cancer registry data have identified significant increases in
incidence over relatively recent times, including the last three decades, particularly among young (ages 25–39
years) women [6,7]. An additional explanation for these high rates is that environmental causes and their associated
mechanisms need to be considered [8]. In particular, many studies suggest that early (i.e., prenatal) exposures and
during other time windows (i.e., puberty, pregnancy, lactation and menopause) when the breast cells are rapidly
dividing may alter BC susceptibility [6,7,9–12].
Exposure to air pollution is an established risk factor for lung cancer [13]. Airborne emission sources from
traffic in particular have been classified as carcinogens by the International Agency for Research on Cancer
(IARC) [14]. However, emerging data are beginning to suggest that higher concentrations of traffic emissions are
associated with elevated BC risk as well [15]. Traffic-related air pollution (TRAP) contains a mixture of several
compounds, such as gaseous pollutants (carbon monoxide, nitrogen dioxide [NO2], sulfur dioxide), particulate
matter (PM), metals and organic compounds including benzene and polycyclic aromatic hydrocarbons (PAH) [16].
Some components of TRAP, including PAH, may act as endocrine disruptors, suggesting possible mechanistic links
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in breast carcinogenesis [14]. These, too, may be more deleterious to breast tissue during the prenatal, pubertal and
pregnancy windows of susceptibility (WOS) to environmental toxicants when the breast tissue is changing in form
and function [17–23].
Environmental toxicants can exert their effects through alteration of epigenetic regulatory mechanisms. By
definition, these mechanisms refer to DNA methylation, post-translational modifications of histone, production
of noncoding RNAs and other events that alter DNA accessibility and chromatin structure to regulate gene
transcription, without altering the DNA sequence [24–28]. Growing evidence suggests that epigenetic regulation and
its effects on gene transcription may play key intermediary steps between environmental exposures during critical
time WOS and BC risk [29–34].
Methods
In order to conduct a systematic review of the evidence addressingwhether TRAPmay induce BC through epigenetic
regulatory mechanisms, we conducted a PUBMED search using the following key words: vehicular traffic exposure
AND breast cancer AND/OR epigenetic/methylation; particulate matter (PM) 2.5 AND breast cancer AND/OR
epigenetic/methylation; PM10 AND breast cancer AND/OR epigenetic/methylation; PAH (polycyclic aromatic
hydrocarbons) AND breast cancer AND/OR epigenetic/methylation; nitrogen dioxide (NO2) AND breast cancer
AND/OR epigenetic/methylation; nitrogen oxide (NOx) AND breast cancer AND/OR epigenetic/methylation.
We included all relevant articles that matched the searched keywords in the article title and abstract. We excluded
manuscripts prior to year 2000, and those not written in the English language. We included two additional studies
related to the topic that were cited in articles we searched but missed the key word search criteria. In this review we
found 14 epidemiological studies that assessed associations between TRAP exposure and BC risk, in which a total
of 26 comparisons were reported. 11 of these comparisons reported a positive association and 15 comparisons were
negative. Five publications linked TRAP exposure to epigenetic alterations in genes that may be related to BC risk.
One animal study provided evidence of TRAP-treatment inducing breast tumorigenesis.
Below, and in Table 1, we summarize the research links that address two questions: Does exposure to TRAP
associate with the development of breast cancer? and Is BC a result of epigenetic responses to TRAP? We consider
both estimates and direct measures of traffic-related specific components (PM, PAH, NO2 and NOx), and review
findings that focused on specific time periods of exposure. We conclude with perspectives on the outstanding
research gaps and future areas of investigation for these prevalent exposures and to discern their effects on a highly
prevalent cancer via epigenetic regulation.
Studies examining vehicular traffic measures
One approach to measuring traffic exposure in BC studies has been to use self-reported data from questionnaires [32–
36]. For example, self-reported childhood (under age of 14 years) residential exposure to TRAP based on recalled
proximity of childhood residence to major roads was not consistently associated with breast cancer, but aspects of
road type (e.g., presence of a median or barrier dividing the road) was associated with increased BC risk:hazard
ratio [HR]: 1.4; 95% CI: 1.0–1.9) [36]. However, these recalled indicators of exposure could be misclassified; even
if nondifferential, the extent of exposure may be inaccurate. Studies that measured exposure to TRAP based on
the extent of vehicular traffic at the nearest cross-street found that those who reportedly lived near very high
vehicular traffic (≥3 lanes) during childhood demonstrated greater risk of BC compared with those who lived
near less vehicular traffic (adjusted HR [aHR])≥3 lanes: 1.4; 95% CI: 1.0–1.9 vs aHR < 3 lanes: 1.1; 95% CI:
0.9–1.3) [36]. However, an increased incidence rate ratio of BC was not observed among participants in the Danish
Diet Cancer and Health cohort that enrolled from 1993 to 1997 and were followed through 2006, when using
major street within 50 m as a marker of exposure to traffic (relative risk [RR]: 0.98; 95% CI: 0.78–1.22) [37].
Other epidemiological studies have measured childhood exposure by linking recalled childhood addresses to
external sources of traffic data. These studies have the advantage of requiring knowledge of residential history
without relying on individuals to recall features of the roads near their homes. For example, the Western New York
Exposure and Breast (WEB) cancer case–control study examined BC risk in relation to traffic emissions estimated
throughout life using a geographic location-based model [34]. Participants were women with primary histologically
confirmed breast cancer, aged 35–79 years. Estimates were retrospectively calculated for traffic emission in women
at menarche, their first birth, and 10 and 20 years before enrollment. WEB reported that higher exposure to traffic
estimates at menarche was associated with higher odds of premenopausal BC (odds ratio [OR]: 2.31; 95% CI:
1.03–5.17) [34]. On the other hand, they did not find any significant associations between higher traffic estimates
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and time of woman’s first birth and premenopausal BC (OR: 1.27; 95% CI: 0.48–3.32). Moreover, associations
were not evident for estimates of traffic exposure at 10 or 20 year before enrollment (10 years prior, OR: 1.58;
95% CI: 0.71–3.54 and 20 years prior, OR: 1.37; 95% CI: 0.64–2.92) [34]. Other proxies for traffic exposure have
included residential history in urban areas [38]. Specifically, Binachon et al. evaluated the association of an urban
(with presumably higher traffic and other particular airborne pollutants) versus rural address both at birth and
during adulthood on BC risk in women from the French E3N cohort (aged 38–66 years at recruitment in 1990).
Being born in an urban area was associated with increased BC risk before (HR: 1.11; 95% CI: 1.05–1.18) and after
(aHR: 1.07; 95% CI: 1.01–1.14) adjustment for known BC risk factors (basal metabolic rate BMI, alcohol intake,
smoking, physical activity). In contrast, living in an urban environment during adulthood was not associated with
greater BC risk, implicating the prenatal, but not adult, WOS [38].
Epigenetic findings
The WEB study measured the association between TRAP exposure and epigenetic differences in the breast
tissue [34]. Callahan et al. examined the DNA methylation patterns among breast tumor samples from women
that were recruited in the WEB study using the same estimates of exposure to TRAP [33]. DNA was extracted
from needle biopsies of tumor samples particularly from regions with at least 80% tumor cells. Pyrosequencing
assays were performed for nine different candidate genes (SFN, SCGB3A1, RARB, GSTP1, CDKN2A, CCND2,
BRCA1, FHIT, SYK) that were previously reported to be methylated in BC and which demonstrated biological
relevance to carcinogenesis. They demonstrated that higher exposure to traffic emissions during menarche was
associated with higher methylation of a breast tumor suppressor gene spleen tyrosine kinase (SYK; OR: 2.37; 95%
CI: 1.05–5.33) [33]. They also reported that cases with higher measures of traffic emissions at first birth and 10
years prior to enrollment demonstrated lower methylation of a breast tumorigenic gene Cyclin D2 (CCND2; OR
[first birth]: 0.40; 95% CI: 0.17–0.93; OR [10 years prior to enrollment]: 0.48; 95% CI: 0.26–0.89) [33]. These
findings suggest that prenatal exposures and adult exposures 10 years prior to diagnosis, may induce epigenetic
programming of a BC gene with deleterious effects later in life.
Particulate matter
Particulate matter (PM) generated by internal combustion engines and through secondary processes is a mixture
of extremely fine particles and liquid droplets that disperse into the air. PM is classified based on its diameter.
These classifications include PM10 (inhalable particles with diameters≤10 µm), PM2.5 (fine inhalable particles
with diameters≤2 µm) and PM10–2.5 which is also referred to as PM coarse. PM-related emissions from traffic
and other combustion sources may include metals, PAH and other particulates (e.g., sulfur dioxide, metals) [39].
Observations collected from satellite-derived and ground-based measures suggest that PM2.5 levels have increased
0.55 µg/m3 per year from 1998 to 2012, largely driven by levels in developing countries [40]. Estimates and direct
measures of airborne PM, often derived from traffic, also have been associated with higher BC risk [41,42]. In some
studies, PM has been shown to be weakly estrogenic and may induce cell proliferation via activation of the estrogen
receptor [43,44], providing a mechanism for carcinogenesis in addition to epigenetic ones.
Examples of epidemiological studies that associated PM exposure with higher risk for BC include the Italian
population-based cohort based in Varese province, northern Italy involving BC patients, first diagnosed at the age
of 50–69 years. Individual adult PM2.5 exposure over the 3 years preceding diagnosis was estimated using satellite
observations and the woman’s home address. The risk of BC death was higher for all three upper quartiles compared
with the lowest in multivariate analyses (HRs of death: second quartile [PM2.5 level 21.10–24.20 µg/m3]: 1.82
[95% CI: 1.15–2.89], third quartile [PM2.5 level 24.20–26.50 µg/m3]: 1.73 [95% CI: 1.12–2.67] and fourth
quartile [PM2.5 level > 26.50 µg/m3]: 1.72 [95% CI: 1.08–2.75] compared with the first quartile [PM2.5 level
< 21.10 µg/m3]) [42]. Bonner et al. found, using the WEB study, that higher exposure to TSP (> 140 µg/m3;
total suspended particles or particles≤50 µm) at birth, but not at menarche, based on weighted distance of home
address to measured TSP concentrations, was not clearly associated with higher adjusted odds of postmenopausal
BC (OR: 2.42; 95% CI: 0.97–6.09) compared with low TSP (< 84 µg/m3 at birth) [41]. Other studies, that either
focused on chronic PM2.5 and PM10 exposure, such as the US-based Sister Study [45] featuring women with family
history of breast cancer, or a shorter time span of 3-year mean levels of PM2.5 and PM10 levels prior to diagnosis,
such as the Danish Nurses cohort [46], or of 2-year modeled moving or cumulative average exposures [47], were
unable to find associations between PM exposure and BC risk.
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Epigenetic findings
There are no data showing direct evidence for PM exposure and increased BC riskmediated via epigenetic regulation.
Epigenomic research led by Plusquin et al. using the EPIC-Italian and EPIC-Dutch cohorts studied long term (over
10 years after enrollment) levels of PM2.5 and PM10 using a land-use regression model in middle aged women
and only found very limited evidence of epigenetic alterations in BC genes. They performed Illumina Infinium R⃝
HumanMethylation450 Bead Chip Array on peripheral blood mononuclear cells (PBMCs) from 454 Italian and
159 Dutch participants. Combined analyses involving both cohorts were essentially negative. Upon evaluating
site-specific methylation differences by study site, they found significantly lower methylation of only one CpG site
(cg03513315) on pescadillo ribosomal biogenesis factor 1 (PES1) that was associated with PM10 exposure in the
EPIC-Italy cohort (β: 0.22; SE: 0.042; p-value: 1.47e-7) [48]. More breast tissue specific research by Li et al. found
that PES1 gene is expressed at higher levels in primary breast cancers compared with normal mammary tissues;
knockdown of PES1 slows down the proliferation of BC cells [49]. Another study reported that PES1 increases the
ERα/ERβ ratio and triggers breast tumor growth [50].
Polycyclic aromatic hydrocarbons
Polycyclic aromatic hydrocarbons (PAH) are the by-products of combustion and enter the human body from a
variety of sources, including inhaling gasoline and diesel-fueled engines coal, coke, and oil burners, and eating grilled
and smoked meats and smoke from cigarettes [51–53]. PAH are lipophilic, can be stored in the breast fat tissue [54],
and have the capacity to bind to the DNA forming PAH–DNA adducts in the breast tissue [57–57]. PAH also have
been found to be directly genotoxic and a potent mutagen [58]. The International Agency for Research on Cancer
(IARC) has cited PAH as possible human and animal carcinogen [51]. Several studies have shown that in breast
epithelial tissues, PAHs are metabolized to their most potent and deleterious state affecting cellular morphology,
cellular division, growth and repair [59–61].
Several in vivo and epidemiological studies have linked PAH exposure with increased breast tumorigenesis [59–
64]. El-Bayoumy et al. gavaged 30-day-old female rats once weekly for 8 weeks with a high dose of the PAH
benzo[a]pyrene (B[a]P (50 µmol/rat/week in 0.5 ml trioctanoin) and conducted analyses at age 41 weeks. The
B[a]P-treated rats developed malignant mammary tumors with increased proliferation and invasion [59]. Two
epidemiological studies, the Long Island Breast Cancer Study (LIBSCP) [64] and the aforementioned WEB [34]
population-based case–control studies, employed similar traffic-related pollution models using geographic locations
that estimated the residential exposure to PAH [34]. The objective in LIBSCPwas to evaluate the association between
residential exposure to B[a]P, as a proxy for traffic-related PAH and BC incidence. Both recent B[a]P exposure over
the preceding 12 months prior to case ascertainment, and long term during 1960–1990 were assessed. Associations
were very modest until they stratified women according to tumor hormone receptor subtype. In adjusted models,
higher recent B[a]P exposure in the top 5% was associated with ER-/PR- (OR: 2.09; 95% CI: 1.08–4.06), but
not ER+/PR+ (OR: 0.74; 95% CI: 0.40–1.38), BC [64]. The WEB study stratified subjects by smoking status
and found life-time nonsmokers had higher odds for premenopausal BC associated with PAH measures in the
2nd (OR: 4.89; 95% CI: 1.34–17.83), 3rd (OR: 6.96; 95% CI: 1.86–26.02) and 4th quartiles (OR: 6.67; 95%
CI: 1.74–25.67) at menarche [34]. Interestingly, they also observed higher odds for postmenopausal BC (OR:
6.23; 95% CI: 1.70–22.82) among nonsmokers in relation to higher PAH exposure at first birth [34]. PAH can
be biotransformed into reactive intermediates that form covalent PAH–DNA adducts. These may cause DNA
damage and possess mutagenic properties to initiate and/or promote breast tumorigenesis [52]. LIBSCP also found
significantly higher odds of BC for women with detectable levels of PAH–DNA in blood in the highest versus
lowest quantile of exposure (OR [highest quantile]: 1.51; 95% CI: 1.04–2.20; vs OR [lowest quantile]: 1.13;
95% CI: 0.71–1.81) [62]. Moreover, the association between recent adult B[a]P exposure in the Long Island Breast
Cancer study project (LIBCSP) cohort and BC incidence was more evident among women with variant alleles in
the DNA repair genes ERCC2 (OR: 2.09; 95% CI: 1.13–3.90) and XRCC1 (OR: 2.32; 95% CI: 1.22–4.49) [63].
Epigenetic findings
PAH-induced altered DNA methylation has been found in both breast cell lines and breast tissues. For example,
MCF7, HCC1806, T47D and MDA-MD-231 BC cell lines were treated with multiple doses of B[a]P, and global
and site-specific changes in DNA methylation patterns were characterized repeatedly over 96 h in culture. While
B[a]P did not induce changes in global methylation in all four cell lines, numerous site-specific changes in DNA
methylation using amplification of intermethylation sites (AIMS) were detected. These included B[a]P-induced
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decreases in methylation of CYP8, a member of the cytochrome P450 superfamily in the MCF7 cells on 96-h
treatment, as well as multiple B[a]P-induced decrease in methylation of genomic repeat elements and several short
interspersed nucleotide elements (SINEs), including one at the telomeric site of the tumor suppressor gene tuberous
sclerosis complex 2 (TSC2) in MCF7 and HCC1806 cell lines. While these tissue culture experiments are limited
in their ability to predict in vivo events, lower methylation in these regions have been associated with losses in
genomic stability which has been implicated in carcinogenesis [65].
In the LIBCSP cohort, White et al. assessed the association between PAH–DNA adducts in blood and breast
tumor tissue stratified by BC candidate gene DNA methylation levels and tumor subtypes. The list of 13 BC
candidate genes studies were known to play an important role in breast tumorigenesis and their promoter regions
were frequently methylated in breast tumor tissues [31,66]. Women with detectable PAH–DNA adducts and signif-
icantly higher methylation of the steroid hormone receptor retinoic acid receptor β (RARβ) gene in breast tumor
tissue (OR: 2.69; 95% CI: 1.02–7.12) were more likely to have ER+/PR+ tumors compared with other subtypes.
Differences in global methylation levels assessed in the blood by PAH–DNA adducts were absent [66]. White et al.,
in a subsequent LIBCSP study, focused on the impact of multiple sources of PAH exposure, including estimates
of traffic-related B[a]P exposure and nontraffic sources, such as current smoking and synthetic log burning, whose
mechanisms could mimic those from PAH emitted from traffic-related sources. Report of current smoking was asso-
ciated with lower breast tissue methylation for death-associated protein kinase 1 (DAPK) a breast tumorigenic gene
(OR: 0.53; 95% CI: 0.28–0.99) and higher B[a]P estimates were associated with higher methylation of TWIST, a
gene that promotes epithelial–mesenchymal transition (OR: 2.79; 95% CI: 1.24–6.3). Moreover, nontraffic PAH
sources from report burning of synthetic logs was associated with higher methylation of RARβ (OR: 1.80; 95% CI:
1.16–2.78), tumor suppressor gene hairpin-induced gene 1 (HIN1; OR: 2.14; 95%CI: 1.34–3.42) and E-cadherin
(CDH1) (OR: 2.26; 95% CI: 1.06–4.79) and lower methylation of BRCA1 (OR: 0.44; 95% CI: 0.30–0.66) and
LINE-1 (OR: 0.59; 95% CI: 0.41–0.86) [31].
Nitrogen dioxide (NO2) & Nitrogen oxide (NOx)
NO2 emissions are primarily derived from the burning of fuel and vehicle exhaust, including those emitted
from cars, trucks and buses, power plants and off-road equipment [32,67], and contribute to the formation of
photochemical smog [68]. There is recent evidence of increasing levels of NO2 and NOx from traffic emission levels
in cities [69]. NO2 levels have been shown to be associated with higher BC incidence in several [45,70] – but not
all – studies [37,68]. Goldberg et al. conducted a population-based, case–control study of street-level concentrations
of NO2 (10 years prior to recruitment) and incident postmenopausal BC in Montreal, Canada using a land-use
regression model [68]. They did not find an increased OR for postmenopausal BC (OR: 1.08; 95% CI: 0.92–1.27)
per interquartile range increase of 3.75 p.p.b. of NO2 [68]. Another study combining 15 cohorts from nine European
countries focusing on a large group of postmenopausal women estimated residence and traffic-related NO2 and
NOx pollution exposure using a land-use regression model [32]. They found that higher NOx exposure over the
preceding 20 years was associated with higher incidence of postmenopausal BC (HR: 1.04; 95% CI: 1.01–1.08 per
increment of 20 µg/m3 NOx) [32]. The Sisters Study, as previously mentioned, also estimated adult exposure to
NO2 using a land-use regression model based on the annual average of (NO2) levels outside their residence using
monitoring data since 1990 until the time of diagnosis and its association to BC risk [45]. They found that each
interquartile range difference of 5.8 p.p.b. NO2 exposure was associated with increased risk of ER+/ PR+ BC
(n = 947 ER+/PR+ cases; RR: 1.10; 95% CI: 1.02–1.19), but not ER-/PR- BC (n = 223 ER-/PR- cases, RR:
0.92; 95% CI: 0.77–1.09) [45]. In a Canadian-based case–control study, postmenopausal women aged 50–76 years
were recruited. Recent NO2 levels were measured at time of recruitment using air samplers located at 22 locations
and land-use regression models and distant NO2 exposure 10 and 21 years previously was estimated based on home
addresses. For each increase in 5 p.p.b. NO2 estimated during the previous 10-year period, the adjusted OR for
postmenopausal BC was 1.31 (95% CI: 1.00–1.71). No association with postmenopausal BC and NO2 exposure
21 years prior (OR: 1.17; 95% CI: 0.91–1.50) [70]. Otherwise, to our knowledge, there are no NO2 exposure
studies that focused on younger WOS and BC risk assessment.
Epigenetic findings
There are no data showing direct evidence for NO2/NOx exposure and increased BC risk mediated via epigenetic
regulation. However, Plusquin et al. used an epigenome-wide DNA methylation approach in the EPIC cohort to
study the link between exposure to NO2 assessed by using a land-use regression model and DNA methylation in
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Figure 1. Traffic-related air pollutants, windows of susceptibility, evidence of epigenetic regulation and breast
cancer risk.Multiple traffic-related emissions, during several WOS that still need to be determined, have been
associated with DNA methylation of genes implicated in breast cancer risk. As examples, traffic-related particulate
matter may hypomethylate pro-tumorigenic gene PES1; exposure to PAH from non-traffic sources has been associated
with hypermethylation of the epithelial mesenchymal transition factor TWIST and hypomethylation a protumorigenic
gene DAPK1; NO2 exposure may hypomethylate protumorigenic genes EPHB2 and LONP1, explaining its association
with higher breast cancer risk. Apart from epigenetic processes, the contributions of other pathways (eg. DNA
damage) still need to be elucidated.
DAPK1: Death associated protein kinase 1; EPHB2: Ephrin type-B receptor 2; LONP1: Lon protease 1; PAH: Polycyclic
aromatic hydrocarbon; PES1: Pescadillo Ribosomal Biogenesis Factor 1; WOS: Windows of susceptibility.
peripheral blood mononuclear cells [48]. They found NO2 exposure was associated with lower methylation of 12
different CpG sites in 11 different genes, including breast tumor suppressor gene Ephrin type-B receptor 2 (EPHB2)
in the EPIC-Italy only [48]. EPHB2 belongs to the family of Eph receptor tyrosine kinase receptors and has been to
shown to be overexpressed in BC as well as to play a role in BC development [71]. Gruzieva et al.meta-analyzed the
associations between prenatal NO2 exposure as indicated by residential addresses at birth using a land-usemodel and
cord blood DNA methylation in four European and North American studies (n = 1508). Prenatal NO2 measures
were associated with lower offspring DNA methylation in cord blood of mitochondria-related genes (CpG sites:
cg12283362, gene: LonP1; cg24172570, gene: HIBADH and cg08973675, gene: SLC25A28) [72]. Interestingly,
LonP1 is essential in BC development and growth [73], suggesting a possible link between prenatal NO2 exposure
and increased BC risk via lower methylation and thereby activation of LonP1.
Conclusion
Does exposure to TRAP associate with the development of breast cancer?
As summarized in Table 1, the evidence favors this conclusion. Associations between TRAP components PAH
and NO2 and BC risk were more consistent. Nie et al. have examined exposures specifically during menarche and
the woman’s first birth [34]. However, the time WOS to exposure appear less specific in many other studies. Most
assessed adult exposure to TRAP exposure over a broad period of time, often measured or estimated in the decades
before diagnosis, neglecting possibly other key time windows during puberty, pregnancy and lactation when the
breast tissue undergoes major structural changes. Further, a widespread bias against publishing negative results may
impact our ability to understand fully the impact of all recent research.
Is BC a result of epigenetic responses to TRAP?
As described above, the supporting data directly implicating epigenetic alterations are limited (Figure 1). However,
we still suspect these mechanisms are important. Mounting evidence also supports the importance of epigenetic
regulation to breast carcinogenesis, even when environmental sources are not examined. One example is the
work from Lessons in Epidemiology and Genetics of Adult Cancer from Youth (LEGACY) girls cohort study
that recently found differentially methylated regions (DMRs) associated with BC family history [74]. LEGACY
investigators studied DNA methylation patterns in white blood cells for 29 candidate BC genes selected from
previous publications in 426 girls (ages 6–13 years), in which 239 were reported with, and 187 without, a BC
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family history. Using targeted bisulfite sequencing they found differentially methylated regions in two genes,
estrogen receptor 1 (ESR1) and SEC16 homolog B, endoplasmic reticulum export factor (SEC16B). Both of
these genes have been reported to play a key role in BC susceptibility and pubertal development, suggesting that
their differential methylation may indicate risk early and prior to adult onset disease [74]. In a nested case–control
study within the prospective Melbourne Collaborative Cohort Study, Severi et al. tested the association between
epigenome-wide DNA methylation levels using Illumina Infinium Human Methylation 450 Bead Chip array in
peripheral blood with the odds of diagnosis of breast cancer. The odds of later developing BC was compared
with mean methylation levels of various regions in the epigenome, including relative to CpGs islands; relative to
repetitive elements and in the gene promoter [75]. Higher mean levels of DNA methylation of CpGs located within
all functional promoter regions were associated with a higher odds of BC (OR: 1.59; 95% CI: 1.07–2.36); whereas,
higher DNA methylation of genomic regions outside promoters was associated with lower odds of BC (OR: 0.69;
95% CI: 0.52–0.93) [75]. These results suggest that epigenomic analyses, even in in peripheral blood, collected
before diagnosis may have utility as predictive biomarkers and thus for early detection of breast cancer.
Future perspective
Given the emerging importance of environmental epigenetic regulation in the development of a number of complex
diseases [24,29,30,76,77], and the growing literature on TRAP and BC risk, more research is needed to elucidate
mechanisms and demonstrate causal effects. Epidemiological studies should focus on discrete WOS, individually
or in combination, when exposure to traffic-related air pollutants may exert its largest effects on BC risk. They
need to consider potential confounders like diet, obesity and access to BC screening [41,64]. Also, sufficiently
powered statistical tests for mediation are needed to inform more mechanistically on the importance of epigenetic
regulation to explaining the links between TRAP exposure and cancer. Translational research should be paired with
determination of epigenomic biomarkers. Controlled models that experimentally expose animals to traffic-related
air pollutants may also lead to a greater understanding of the tissue-specific signaling pathways, including potential
epigenetic mechanisms, that underlie BC risk. In addition, much needed experimental studies may inform further
alternate pathways besides epigenetic regulation, such as PM-induced endocrine disruption [43,44] and PAH-induced
DNA damage [52], that could underlie BC risk.
The gaps in our understanding of epigenetic regulation of BC risk following exposure to air pollution compared
with that in associationwith other tissues and diseases are striking. For example,Hesselbach et al. analyzed the impact
of ambient PM2.5 from biomass combustion on the transcriptome and methylome of primary human bronchial
epithelial BEAS-2B cells using the Affymetrix HG-U133 Plus 2.0 Array and Illumina HumanMethylation450
Bead Chip, respectively. They found PM2.5-induced differentially methylated CpGs in the CpG islands, including
differentially methylated CpGs in the promoter region. These PM2.5 induced differentially methylated genes
correlated with their mRNA expression and were functionally linked to pathways that play a prominent role in
lung cancer [24]. Another study investigated the association of prenatal PM2.5 and PM10 exposure estimates from
Southern California Children’s Health Study air quality monitoring data based on residential address at birth on
DNA methylation (Human Methylation 450 Bead Chip) of 178,309 promoter regions in archived bloodspots
from 240 newborns. Breton et al. reported an association between prenatal PM2.5 and PM10 exposure at birth
and higher methylation in the promoter region of transmembrane 9 superfamily member 2 (TM9SF2), ubiquitin-
conjugating enzyme E2 (UBE2S) and lower methylation of tudor domain containing 6 (TDRD6) genes which may
be associated with asthma [76]. Gref et al. sought to determine gene–environment interaction effects on childhood
asthma in three European cohorts using genome-wide single-nucleotide polymorphism (SNP) data fromAffymetrix
Genome169 wide Human SNP array 5.0 and outdoor NO2 exposure using a land-use regression model. Several
SNPs showed evidence of positive interactions between NO2 exposure and childhood asthma. Lower methylation
was found in one of them, the differential discs, large homolog 2 (DLP2) gene. Lower methylation of DLP2 was
also replicated in blood samples obtained during in vivo experiments prior to and following 2 h of diesel exposure
(300 µg/m3, containing high levels of NO2 at 0.22 ppm) within a small group of nonsmoking asthmatics [77].
In summary, future research studies that conduct epigenome-wide studies, with attention to tissue specificity,
following exposure to TRAP across key WOS on increased BC risk, are greatly needed. We expect these to occur
in the upcoming years. Hopefully such research will identify environmental exposures of concern, allowing for
interventions and greater surveillance for those at high risk for onset of future disease.
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Executive summary
Traffic-related air pollutant exposure & breast cancer risk
• Emerging data suggest that higher concentrations of traffic pollutants are associated with elevated breast cancer
(BC) risk.
• Breast tissue may be susceptible to environmental toxicants during prenatal, pubertal and pregnancy time
periods of exposure due to its changing form and function.
• Environmental toxicants may exert effects through alteration of epigenetic regulatory mechanisms.
Vehicular traffic measures
• The association between vehicular traffic measures and BC risk appears inconsistent.
• Higher exposure to traffic exposure during menarche was associated with higher odds of premenopausal breast
cancer and higher methylation of breast tumor suppressor gene spleen tyrosine kinase (SYK).
Particulate matter
• The association between traffic-related particulate matter (PM) exposure and BC risk appears inconsistent.
• PM exposure during adulthood may lower methylation of breast protumorigenic gene PES1.
Polycyclic aromatic hydrocarbons
• Traffic-related polycyclic aromatic hydrocarbons (PAH) exposure appears associated with increased BC risk.
• Women with detectable PAH–DNA adducts and methylated steroid hormone receptor RARβ were more likely to
have ER+/PR+ tumors.
Nitrogen dioxide (NO2) & nitrogen oxide (NOx)
• Traffic-related NO2 exposure is associated with increased BC risk.
• Traffic-related NO2 may lower methylation of protumorigenic genes EPHB2 and LONP1.
Future perspective
• Epigenome-wide research across possible time windows of susceptibility in mammary tissue and on BC risk is
greatly needed.
• These should pay particular attention to tissue specificity following exposures to traffic-related air pollution.
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